KRAS and BRAF Mutational Status in Primary Colorectal Tumors and Related Metastatic Sites: Biological and Clinical Implications

By Italiano Antoine  

Annals of Surgical Oncology, Vol. 17, Iss. 5, 2010-05 ,pp. : 1429-1434

Springer Publishing Company

Access to resources Recommend Favorite

Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 2, 2012-02 ,pp. : 163-171

Bentham Science Publishers

Access to resources Recommend Favorite

EGFR Mutations, Gene Amplification, and Protein Expression and KRAS Mutations in Primary and Metastatic Tumors of Nonsmall Cell Lung Cancers and Their Clinical Implications: A Meta-Analysis

By Han Chengbo   Ma Jietao   Zhao Jianzhu   Zhou Yang   Jing Wei   Zou Huawei  

Cancer Investigation, Vol. 29, Iss. 9, 2011-10 ,pp. : 626-634

Informa Healthcare

Access to resources Recommend Favorite

Comparison of K-ras mutations in lung, colorectal and gastric cancer

By Peng Nanqiu   Zhao Xintai  

Oncology Letters, Vol. 8, Iss. 2, 2014-08 ,pp. : 561-565

Spandidos Publications

Access to resources Recommend Favorite

Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer

By Nakanishi Ryota   Harada Jun   Tuul Munkhbold   Zhao Yan   Ando Koji   Saeki Hiroshi   Oki Eiji   Ohga Takefumi   Kitao Hiroyuki   Kakeji Yoshihiro   Maehara Yoshihiko  

International Journal of Clinical Oncology, Vol. 18, Iss. 6, 2013-12 ,pp. : 1042-1048

Springer Publishing Company

Access to resources Recommend Favorite